Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ashwani Kesarwani"'
Autor:
Tong Hu, Milan Chheda, Albert Kim, Ashwani Kesarwani, Amanda De Andrade Costa, Jeremy N Rich, Pei-Yong Shi, Michael S Diamond
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/82f29ec4745947e69a37e43090e8f89c
Autor:
K. Varsha Mohan, Alaknanda Mishra, Abaranjitha Muniyasamy, Prakriti Sinha, Parul Sahu, Ashwani Kesarwani, Kshama Jain, Perumal Nagarajan, Vinod Scaria, Manisha Agarwal, Naseem S. Akhter, Chanda Gupta, Pramod Upadhyay
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment. Some of the key non-genetic factors wh
Externí odkaz:
https://doaj.org/article/f434b379cc6343818acff51001d5c769
Autor:
Ashwani Kesarwani, Parul Sahu, Kshama Jain, Prakriti Sinha, K. Varsha Mohan, Puja S. Nagpal, Surender Singh, Rana Zaidi, Perumal Nagarajan, Pramod Upadhyay
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Due to the limited utility of Bacillus Calmette–Guérin (BCG), the only approved vaccine available for tuberculosis, there is a need to develop a more effective and safe vaccine. We evaluated the safety and efficacy of a dry powder aerosol
Externí odkaz:
https://doaj.org/article/5a53b440eb214cefafd4123e85eecc97
Autor:
Alaknanda Mishra, K. Varsha Mohan, Perumal Nagarajan, Srikanth Iyer, Ashwani Kesarwani, Madhu Nath, Laxmi Moksha, Jashdeep Bhattacharjee, Barun Das, Kshama Jain, Parul Sahu, Prakriti Sinha, T. Velapandian, Pramod Upadhyay
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-17 (2020)
Abstract Background Cell therapy is one of the most promising therapeutic interventions for retinitis pigmentosa. In the current study, we aimed to assess if peripheral blood-derived monocytes which are highly abundant and accessible could be utilize
Externí odkaz:
https://doaj.org/article/2e2d4ff2bd964a89ab30da399e57382a
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background With the aim of preparing a more effective, safe and economical vaccine for tuberculosis, inhalable live mycobacterium formulations were evaluated. Methods Alginate particles in the size range of 2–4 μm were prepared by encapsu
Externí odkaz:
https://doaj.org/article/4b78fc5098f548ee83f80ecd4281d20a
Autor:
Alaknanda Mishra, Barun Das, Madhu Nath, Srikanth Iyer, Ashwani Kesarwani, Jashdeep Bhattacharjee, Shailendra Arindkar, Preeti Sahay, Kshama Jain, Parul Sahu, Prakriti Sinha, Thirumurthy Velpandian, Perumal Nagarajan, Pramod Upadhyay
Publikováno v:
Biology Open, Vol 6, Iss 4, Pp 449-462 (2017)
Retinitis pigmentosa (RP) is a common retinal degeneration disease caused by mutation in any gene of the photo transduction cascade and results in photoreceptor dystrophy. Over decades, several animal models have been used to address the need for the
Externí odkaz:
https://doaj.org/article/b6a901c473594178b46ea82b9446f006
Publikováno v:
F1000Research, Vol 7 (2018)
The cultivation of mycobacteria often requires the use of several antibiotics to limit the growth of other rapidly growing micro-flora present in the growth medium. This antibiotic cocktail is one of the most expensive reagents required for mycobacte
Externí odkaz:
https://doaj.org/article/d391d2303885483396a3b7a5d268a7ca
Autor:
Jacob M Puliyel, K. Varsha Mohan, Vivek Ranjan, Ashwani Kesarwani, Pramod Upadhyay, Alaknanda Mishra, Sandeep Narayan Lal
Publikováno v:
Viral Immunology. 33:72-76
Stress-induced subclinical reactivation of varicella-zoster virus (VZV) has been studied previously. However, subclinical reactivation of VZV induced by the stress of pregnancy has not been investigated. The objective was to study varicella DNA and v
Autor:
Ashwani Kesarwani, Sachendra Singh Bais, Sharmila Nair, Amanda Andrade De Costa, Tong Hu, Pei-Yong Shi, Michael S Diamond, Milan G Chheda
Publikováno v:
Neuro-Oncology. 24:vii214-vii214
We are developing ZIKV as a therapy for GBM. We previously demonstrated ZIKV specifically kills GBM stem cells. Using GL261 and CT2A mouse models, ZIKV induces a CD8+ T-cell mediated anti-tumor response and leads to 65% and 40% long term survivors, r
Autor:
Pramod Upadhyay, K. Varsha Mohan, Ashwani Kesarwani, Prakriti Sinha, K. K. Jain, Surender Singh, Parul Sahu, Rana Zaidi, Perumal Nagarajan, Puja S. Nagpal
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Due to the limited utility of Bacillus Calmette–Guérin (BCG), the only approved vaccine available for tuberculosis, there is a need to develop a more effective and safe vaccine. We evaluated the safety and efficacy of a dry powder aerosol (DPA) fo